CClinicalTrials.gg
CompletedNCT05573646Updated Aug 23, 2024

Online Group-based Dual-task Training to Improve Cognitive Function of Community-dwelling Older Adults

An interventional study of Dual-task training and Attention Control in Aging Well, sponsored by The University of Hong Kong. Completed at 1 site in Hong Kong. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-23.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Objectives: This study aims to explore the feasibility, acceptance, and efficacy of online group-based dual-task training as an intervention for improving cognitive function among community-dwelling older adults.

Hypothesis to be tested: We hypothesize that after the intervention, there will be an improvement in the participants' cognitive function as compared with pre-intervention status and with the control group. Also, lower-limb muscle strength and psychosocial wellbeing will be improved after the intervention.

Design and subjects: This is a randomised controlled feasibility study. The target population is community-dwelling older adults with access to an online meeting platform. About 75 participants will be recruited and randomised to the intervention and attention control groups in a ratio of 2:1. Intervention group will receive 60 minutes of online group-based dual-task training twice a week for 12 weeks led by a trained facilitator. Cognitive training components include arithmetic operation, verbal fluency, and upper limb/finger movement. Physical training components are chair-based exercises. The training components will be selected using a co-design approach.

Instruments: Memory Inventory in Chinese (MIC), Digit Span Test, Victoria Stroop Test, Montreal Cognitive Assessment 5-Minutes (Hong Kong Version).

Main outcome measures: Subjective memory complaints as measured by MIC.

02

Conditions studied

  • Aging Well
03

In context

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,262 studies on the registry; 340 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • aged 65 years and above,
  • no communication problems,
  • able to communicate in Chinese, and
  • able to use an online meeting platform.

Exclusion criteria

Exclusion Criteria:

  • contraindications to chair-based exercises, and
  • engagement in any kind of cognitive training three months prior to the study or during the study period.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
76 participants (actual)

Study arms

  • Experimental
    Dual-task training

    Dual-task training group

    Other: Dual-task training

  • Other
    Attention control

    Attention control group

    Other: Attention Control

Interventions

  • OtherDual-task training

    Participants will receive a one-hour online group-based dual-task training session twice a week for 12 weeks, giving a total intervention time of 24 hours. A co-design approach will be adopted to develop the training components in the dual-tasks. For the cognitive training component, arithmetic operation, verbal fluency, and upper limb/ finger movements are included. For the physical training component, we select chair-based exercises are included. A group-based training mode led by a facilitator will be adopted. During the session, participants will be asked to turn on their camera so that they can see and interact with each other. They will also have their audio on as they will have to participate in the cognitive tasks by voicing out their answers.

  • OtherAttention Control

    Participants will receive eight one-hour online group-based interactive education on health topics other than exercise and cognitive health.

06

What researchers measure

Primary outcomes

  1. Change from baseline subjective memory complaints at 6 weeks

    Measured by Memory Inventory in Chinese. The sum of score ranges from 0 to 108, higher score indicates more memory complaints.

    Time frame: Six weeks after baseline

  2. Change from baseline subjective memory complaints at 12 weeks

    Measured by Memory Inventory in Chinese. The sum of score ranges from 0 to 108, higher score indicates more memory complaints.

    Time frame: 12 weeks after baseline

  3. Change from baseline subjective memory complaints at 18 weeks

    Measured by Memory Inventory in Chinese. The sum of score ranges from 0 to 108, higher score indicates more memory complaints.

    Time frame: 18 weeks after baseline

Secondary outcomes

  1. Change from baseline cognitive status at 6 weeks

    Measured by the Montreal Cognitive Assessment 5-Minutes (Hong Kong Version) (HK-MoCA 5-Min) protocol. The total score ranges from 0 to 30; a higher score indicates better cognitive status.

    Time frame: Six weeks after baseline

  2. Change from baseline cognitive status at 12 weeks

    Measured by the Montreal Cognitive Assessment 5-Minutes (Hong Kong Version) (HK-MoCA 5-Min) protocol. The total score ranges from 0 to 30; a higher score indicates better cognitive status.

    Time frame: 12 weeks after baseline

  3. Change from baseline cognitive status at 18 weeks

    Measured by the Montreal Cognitive Assessment 5-Minutes (Hong Kong Version) (HK-MoCA 5-Min) protocol. The total score ranges from 0 to 30; a higher score indicates better cognitive status.

    Time frame: 18 weeks after baseline

  4. Change from baseline working memory at 6 weeks

    Measured by Digit Span Test. The longer the series, the better the condition.

    Time frame: Six weeks after baseline

  5. Change from baseline working memory at 12 weeks

    Measured by Digit Span Test. The longer the series, the better the condition.

    Time frame: 12 weeks after baseline

  6. Change from baseline working memory at 18 weeks

    Measured by Digit Span Test. The longer the series, the better the condition.

    Time frame: 18 weeks after baseline

  7. Change from baseline executive function at 6 weeks

    Measured by Chinese version of the Victoria Stroop Test, with more time and errors as worse condition.

    Time frame: Six weeks after baseline

  8. Change from baseline executive function at 12 weeks

    Measured by Chinese version of the Victoria Stroop Test, with more time and errors as worse condition.

    Time frame: 12 weeks after baseline

  9. Change from baseline executive function at 18 weeks

    Measured by Chinese version of the Victoria Stroop Test, with more time and errors as worse condition.

    Time frame: 18 weeks after baseline

  10. Change from baseline lower-limb muscle strength at 6 weeks

    Measured by the 5-times chair stand task. The longer the time participants use to finish the task, the poorer the performance.

    Time frame: Six weeks after baseline

  11. Change from baseline lower-limb muscle strength at 12 weeks

    Measured by the 5-times chair stand task. The longer the time participants use to finish the task, the poorer the performance.

    Time frame: 12 weeks after baseline

  12. Change from baseline lower-limb muscle strength at 18 weeks

    Measured by the 5-times chair stand task. The longer the time participants use to finish the task, the poorer the performance.

    Time frame: 18 weeks after baseline

  13. Change from baseline happiness at 6 weeks

    Measured by the Chinese version of the 4-item Subjective Happiness Scale. The score is the average of the four items, and ranges from 1 to 7; a higher score indicates a higher happiness level.

    Time frame: Six weeks after baseline

  14. Change from baseline happiness at 12 weeks

    Measured by the Chinese version of the 4-item Subjective Happiness Scale. The score is the average of the four items, and ranges from 1 to 7; a higher score indicates a higher happiness level.

    Time frame: 12 weeks after baseline

  15. Change from baseline happiness at 18 weeks

    Measured by the Chinese version of the 4-item Subjective Happiness Scale. The score is the average of the four items, and ranges from 1 to 7; a higher score indicates a higher happiness level.

    Time frame: 18 weeks after baseline

  16. Change from baseline depressive symptoms at 6 weeks

    Measured by the Patient Health Questionnaire-9. The scale ranged from 0 to 27, higher score indicates higher level of depressive symptoms.

    Time frame: Six weeks after baseline

  17. Change from baseline depressive symptoms at 12 weeks

    Measured by the Patient Health Questionnaire-9. The scale ranged from 0 to 27, higher score indicates higher level of depressive symptoms.

    Time frame: 12 weeks after baseline

  18. Change from baseline depressive symptoms at 18 weeks

    Measured by the Patient Health Questionnaire-9. The scale ranged from 0 to 27, higher score indicates higher level of depressive symptoms.

    Time frame: 18 weeks after baseline

  19. Change from baseline social isolation/integration at 6 weeks

    Measured by the Chinese version of the 6-item Lubben Social Network Scale. The total score ranges from 0 to 30; a higher score indicates a better social network.

    Time frame: Six weeks after baseline

  20. Change from baseline social isolation/integration at 12 weeks

    Measured by the Chinese version of the 6-item Lubben Social Network Scale. The total score ranges from 0 to 30; a higher score indicates a better social network.

    Time frame: 12 weeks after baseline

  21. Change from baseline social isolation/integration at 18 weeks

    Measured by the Chinese version of the 6-item Lubben Social Network Scale. The total score ranges from 0 to 30; a higher score indicates a better social network.

    Time frame: 18 weeks after baseline

  22. Change from baseline instrumental activity of daily living at 6 weeks

    Measured by Lawton's eight selected tasks. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias.

    Time frame: Six weeks after baseline

  23. Change from baseline instrumental activity of daily living at 12 weeks

    Measured by Lawton's eight selected tasks. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias.

    Time frame: 12 weeks after baseline

  24. Change from baseline instrumental activity of daily living at 18 weeks

    Measured by Lawton's eight selected tasks. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women and 0 through 5 for men to avoid potential gender bias.

    Time frame: 18 weeks after baseline

07

Study locations

1 site
  • Nursing Home
    Hong Kong, Hong Kong
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05573646
Lead sponsor
The University of Hong Kong
Collaborators
Health and Medical Research Fund
Responsible party
Dr. Pui-Hing Chau (Associate Professor, The University of Hong Kong) — Principal investigator
First posted
Oct 10, 2022
Start date
Oct 1, 2022
Primary completion
Jun 30, 2024
Completion
Jun 30, 2024
Last update
Aug 23, 2024

Study contacts

Pui Hing Chau, PhD
principal investigator · School of Nursing, The University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion